Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Total 13F shares
-
38,900
-
Share change
-
+24,600
-
Total reported value
-
$203,447
-
Price per share
-
$5.23
-
Number of holders
-
1
-
Value change
-
+$128,658
-
Number of buys
-
1
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q4 2023
As of 31 Dec 2023,
EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
38,900 shares.
The largest 10 holders included
BlackRock Inc., JANUS HENDERSON GROUP PLC, BRANDES INVESTMENT PARTNERS, LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, AQR CAPITAL MANAGEMENT LLC, LSV ASSET MANAGEMENT, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.